Arthritis Research UK Epidemiology Unit, Faculty of Medical and Human Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, England.
JAMA. 2013 Aug 21;310(7):722-30. doi: 10.1001/jama.2013.243229.
There is no consensus regarding the efficacy of lateral wedge insoles as a treatment for pain in medial knee osteoarthritis.
To evaluate whether lateral wedge insoles reduce pain in patients with medial knee osteoarthritis compared with an appropriate control.
Databases searched include the Cochrane Central Register of Controlled Trials, EMBASE, AMED, MEDLINE, CINAHL Plus, ScienceDirect, SCOPUS, Web of Science, and BIOSIS from inception to May 2013, with no limits on study date or language. The metaRegister of Controlled Trials and the NHS Evidence website were also searched.
Included were randomized trials comparing shoe-based treatments (lateral heel wedge insoles or shoes with variable stiffness soles) aimed at reducing medial knee load, with a neutral or no wedge control condition in patients with painful medial knee osteoarthritis. Studies must have included patient-reported pain as an outcome.
Trial data were extracted independently by 2 researchers using a standardized form. Risk of bias was assessed using the Cochrane Risk of Bias tool by 2 observers. Eligible studies were pooled using a random-effects approach.
Change in self-reported knee pain at follow-up.
Twelve trials met inclusion criteria with a total of 885 participants of whom 502 received lateral wedge treatment. The pooled standardized mean difference (SMD) suggested a favorable association with lateral wedges compared with control (SMD, -0.47; 95% CI, -0.80 to -0.14); however, substantial heterogeneity was present (I2 = 82.7%). This effect size represents an effect of -2.12 points on the 20-point Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain scale. Larger trials with a lower risk of bias suggested a null association. Meta-regression analyses showed that higher effect sizes (unstandardized β, 1.07 [95% CI, 0.28 to 1.87] for trials using a no treatment control) were seen in trials using a no wedge treatment control group (n = 4 trials; SMD, -1.20 [95% CI, -2.09 to -0.30]) and lower effect sizes (unstandardized β, 0.26 [95% CI, 0.002 to 0.52] for each bias category deemed low risk) when the study method was deemed at low risk of bias. Among trials in which the control treatment was a neutral insole (n = 7), lateral wedges showed no association (SMD, -0.03 [95% CI, -0.18 to 0.12] on WOMAC; this represents an effect of -0.12 points), and results showed little heterogeneity (I2 = 7.1%).
Although meta-analytic pooling of all studies showed a statistically significant association between use of lateral wedges and lower pain in medial knee osteoarthritis, restriction of studies to those using a neutral insole comparator did not show a significant or clinically important association. These findings do not support the use of lateral wedges for this indication.
对于外侧楔形鞋垫作为治疗内侧膝骨关节炎疼痛的疗效,目前尚无共识。
评估外侧楔形鞋垫与适当的对照相比是否能减轻内侧膝骨关节炎患者的疼痛。
从建库到 2013 年 5 月,我们检索了 Cochrane 对照试验中心注册库、EMBASE、AMED、MEDLINE、CINAHL Plus、ScienceDirect、SCOPUS、Web of Science 和 BIOSIS 等数据库,对研究日期或语言没有任何限制。还检索了 metaRegister of Controlled Trials 和 NHS Evidence 网站。
纳入的随机试验比较了鞋类治疗(外侧足跟楔形鞋垫或鞋底具有可变刚度的鞋子),旨在减轻内侧膝关节负荷,在有疼痛的内侧膝骨关节炎患者中,使用中性或无楔形物对照条件。研究必须将患者报告的疼痛作为结局。
由 2 名研究人员使用标准化表格独立提取试验数据。由 2 名观察者使用 Cochrane 偏倚风险工具评估偏倚风险。使用随机效应方法对合格研究进行汇总。
随访时自我报告的膝关节疼痛变化。
12 项试验符合纳入标准,共有 885 名参与者,其中 502 名接受了外侧楔形治疗。汇总的标准化均数差(SMD)表明,与对照组相比,外侧楔形治疗具有良好的相关性(SMD,-0.47;95%CI,-0.80 至 -0.14);然而,存在很大的异质性(I2=82.7%)。这个效应大小代表 Western Ontario 和 McMaster 大学关节炎指数(WOMAC)疼痛量表上的 20 分中降低了 2.12 分。较小的、偏倚风险较低的试验则提示无关联。Meta 回归分析显示,在使用无楔形物对照(n=4 项试验)的试验中,较高的效应大小(未标准化β,1.07 [95%CI,0.28 至 1.87])和较低的效应大小(未标准化β,0.26 [95%CI,0.002 至 0.52])分别在使用无楔形物对照组(n=4 项试验)和低偏倚风险类别(SMD,-1.20 [95%CI,-2.09 至 -0.30])中观察到。在对照组为中性鞋垫的试验中(n=7),外侧楔形物没有关联(SMD,-0.03 [95%CI,-0.18 至 0.12],WOMAC;这代表降低了 0.12 分),并且结果显示异质性较小(I2=7.1%)。
虽然所有研究的荟萃分析显示,外侧楔形物的使用与内侧膝骨关节炎疼痛降低之间存在统计学上的显著关联,但将研究仅限于使用中性鞋垫对照的研究时,并未显示出显著或临床上重要的关联。这些发现不支持将外侧楔形物用于该适应症。